Baupost Group’s Kindred Biosciences, Inc. KIN Stock Holding History

Baupost Group’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,011,584	Closed	-$15M	–	49
2016 Q3	$15M	Sell	3,011,584 -2,264	-0.1%	-$9.57K	0.21%	37
2016 Q2	$10.7M	Hold	3,013,848	–	–	0.14%	35
2016 Q1	$10.4M	Hold	3,013,848	–	–	0.15%	31
2015 Q4	$10.2M	Hold	3,013,848	–	–	0.19%	32
2015 Q3	$15.7M	Hold	3,013,848	–	–	0.26%	34
2015 Q2	$20.6M	Hold	3,013,848	–	–	0.34%	27
2015 Q1	$21.5M	Hold	3,013,848	–	–	0.36%	25
2014 Q4	$22.5M	Hold	3,013,848	–	–	0.44%	23
2014 Q3	$27.9M	Buy	3,013,848 +250,000	+9%	+$3.38M	0.49%	20
2014 Q2	$51.5M	Hold	2,763,848	–	–	0.84%	17
2014 Q1	$51.2M	Sell	2,763,848 -136,152	-5%	-$2.6M	1.24%	14
2013 Q4	$32.4M	Buy	+2,900,000	New	+$34.6M	0.92%	13

Other funds holding KIN

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Baupost Group's KIN Position: Q4 2016 in Review

Baupost Group sold out of Kindred Biosciences, Inc. (KIN) in Q4 2016, closing a stake of 3,011,584 shares — an estimated $15M sold.

Baupost Group first reported a position in KIN in Q4 2013 and held it in 12 quarters. The position peaked at $51.5M in Q2 2014. 43 funds tracked by Wall St. Rank hold KIN as of Q4 2016.

Baupost Group reported no remaining Kindred Biosciences, Inc. position as of Q4 2016 after selling out during the quarter.
Baupost Group sold 3,011,584 Kindred Biosciences, Inc. shares in Q4 2016, an estimated $15M.
Baupost Group first reported a position in Kindred Biosciences, Inc. in Q4 2013 and held it in 12 quarters.
Baupost Group's Kindred Biosciences, Inc. position peaked at $51.5M in Q2 2014.
43 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2016.

Based on Baupost Group's 13F filing for Q4 2016, filed 14 Feb 2017.